MedTrace Logo

Evaluation of Prolidase in Obstructive Sleep Apnea Syndrome

NCT03563118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2018-06-20

No results posted yet for this study

Summary

Obstructive sleep apnea (OSA) is a highly prevalent breathing disorder in sleep. We have aimed to evaluate the relationship between OSA and prolidase activity, the oxidative stress index (OSI), total antioxidative capacity (TAC), and total oxidative capacity (TOC) and the relationship between carotid intima media thickness (CIMT).

Conditions

  • Obstructive Sleep-Apnea Syndrome

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Havva Sayhan · Sakarya University Research and Training Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-09-01
Completion
2018-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03563118 on ClinicalTrials.gov